INMD News and Press, InMode Ltd. From 09/02/22

Summary I called InMode a buy in June before it rallied as much as 58%. We've pulled back a bunch, and I think we likely have a local bottom in place. I am reloading on InMode as I think it's ready for another rally. This past June I posted a bull thesis on medical d...

InMode to Present at the Baird 2022 Global Healthcare Conference PR Newswire YOKNEAM, Israel , Aug. 30, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca ...

The popularity of cosmetic procedures is unquestionably on the rise. Yet two major players in the space have seen their stocks struggle this year. Major pharmaceutical AbbVie (NYSE: ABBV) is plagued by concerns about the impending patent cliff on its top-selling drug. At the sam...

InMode to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1-on-1 Conference InMode to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1-on-1 Conference PR Newswire YOKNEAM, Israel , Aug. 8, 2022 /PRNew...

Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year. Sometimes stocks fall because something bad happens within a business. But stocks can fall for no reason at all during be...

Shares of medical device company InMode (NASDAQ: INMD) jumped 48.3% in July, according to data provided by S&P Global Market Intelligence . The stock performed mostly in line with the S&P 500 during the month with the exception of two monster days. The first cam...

InMode is up more than 50% since July 1 on higher guidance for FY22 and yet another record quarter in Q2. InMode's business has never been in better shape from a fundamental analysis point of view - its growing internationally, successfully launching new products and maintaining insan...

INMD stock will likely double, given its aggressive international expansion and entrance into the medical segment. The fact that INMD continues to report stellar gross margins of over 80%, underscores its robust profitability and excellent cost management thus far. Therefore, we e...

Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q2 2022 Earnings Call Jul 28, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: InMode Ltd. (INMD) Q2 2022 Earnings Call Transcript

Shares of medical-device company InMode (NASDAQ: INMD) surged on Thursday after the company reported financial results for the second quarter of 2022. The company keeps beating expectations, and investors are celebrating it today. As of 3 p.m. ET, InMode stock was up 14%. In Q2,...